Objectives: In 2008-09, the KPC carbapenemase epidemiology in Poland was dominated by a Klebsiella pneumoniae ST258 KPC-2 outbreak in Warsaw and its administrative region. The aim of this study was to analyse the situation in 2010-14, with a focus on new outbreaks in other parts of the country.
Introduction
Carbapenemase-producing Enterobacteriaceae (CPE) are responsible largely for the current global crisis in medicine of bacterial infections. They express three major types of carbapenemhydrolysing enzymes, namely Klebsiella pneumoniae carbapenemases (KPCs), metallo-b-lactamases (MBLs) and OXA-48-like oxacillinases. 1 Organisms with KPCs were identified first in the USA in 1996, 2 followed by many other countries, 1, 3 and the enzymes hydrolyse all b-lactams, with poorer activity against cefoxitin and ceftazidime. 2, 4 Of 20 variants reported so far (ftp://ftp.ncbi.nlm. nih.gov/pathogen/betalactamases/), KPC-2 and -3 are predominant, so is K. pneumoniae among the host species. 5, 6 Although KPCs have been found in multiple K. pneumoniae STs, [7] [8] [9] [10] [11] [12] they are specifically associated with the clonal group CG258, having ST258 as a central genotype. 5, 6, 13 ST258 is essentially responsible for local outbreaks and the global spread of the KPC CPE, 3, 5, 6, 8, 14, 15 and is followed by close relatives, such as ST512. [16] [17] [18] The WGS-based studies revealed that ST258 emerged from K. pneumoniae ST11 by large recombination with ST442 and acquisition of an integrative conjugative element ICEKp258.2 19 that may specify factors involved in epidemicity of ST258/ST512. 5, 13, 20, 21 The following recombination, replacing the ST442-like capsular polysaccharide synthesis operon (cps) by that specific for ST42, caused diversification of the lineage into clades II and I, respectively, which apparently correlate with KPC-3 and -2, respectively. 5, 19, [21] [22] [23] [24] bla KPC genes are located in Tn4401 transposon variants, differing mostly by changes in the bla KPC promoter region. [25] [26] [27] [28] These elements have been observed in various plasmids; 7, 9, 12, [29] [30] [31] [32] their group, The National Reference Centre for Susceptibility Testing (NRCST) in Warsaw is responsible for the CPE surveillance in Poland, collecting suspected isolates from clinical microbiology laboratories together with basic clinical and epidemiological data. The first KPC case was confirmed in Warsaw in 2008, 45 followed soon by an outbreak in the city and its administrative region Mazowieckie. 15 Here we describe the situation in the country in 2010-14, with a focus on new regions that experienced remarkable KPC outbreaks.
Methods

KPC cases and bacterial isolates
In 2010-14, the NRCST confirmed a total of 701 isolates from 608 patients in Poland to be KPC producers. The patients were diagnosed in 84 hospitals and 21 outpatient clinics, and originated mainly (n " 584; 96.1%) from 5 of 16 major regions: Mazowieckie, Swiętokrzyskie, Lubelskie, Podlaskie and Sla˛skie ( Figure 1 and Table 1 ). Four patients had KPC producers of two species, giving in total 602 K. pneumoniae (98.4%), 5 Escherichia coli, 2 Citrobacter freundii, 2 Enterobacter cloacae and 1 Klebsiella oxytoca isolate.
Species of all isolates was confirmed with VITEK 2 (bioMérieux, Marcyl' Etoile, France), and KPCs were detected phenotypically and by PCR (see below). The detailed study was performed on 173 isolates (169 K. pneumoniae, 1 E. coli, 2 C. freundii and 1 E. cloacae) from 2010 to 2012 (Table 2) . These included all 156 non-duplicate isolates from outbreaks in Swiętokrzyskie, Lubelskie, Podlaskie and Sla˛skie, 1 isolate from Swiętokrzyskie linked to hospitalization in Italy and 6 isolates from Sla˛skie associated with patient transfers from Warsaw and Swiętokrzyskie. As the K. pneumoniae KPC from Mazowieckie had been analysed previously, 15, 22 in this study the region was represented by two C. freundii and one E. cloacae isolates from Warsaw that were the only KPC strains of other species in the area. The last seven K. pneumoniae isolates were from Ł od z, Olsztyn and Krak ow, all being KPC isolates outside the outbreak regions in 2010-12.
b-Lactamase identification
KPCs were detected phenotypically, using the disc test with phenylboronic acid, 46 followed by PCR. 45 All bla KPC gene amplicons were digested by RsaI (Thermo Scientific, Vilnius, Lithuania), distinguishing bla KPC-2 -and bla KPC-3 -like variants, 47 and those for 34 representative isolates were sequenced. 45 All isolates were subjected to b-lactamase isoelectric focusing as described previously, 48 followed by PCRs to detect bla CTX-M-1 -, bla SHV-5/-12 -and bla TEMlike genes. 15, 49, 50 The bla genes were sequenced for 20 selected isolates.
Tn4401 analysis
The polymorphism of bla KPC -carrying Tn4401-like transposons was analysed in all isolates by PCR mapping. 25 
Typing and subtyping
All isolates were typed by PFGE, using the XbaI enzyme (Thermo Scientific) 51 ; banding patterns were analysed visually according to Tenover et al. 52 Thirty-four isolates (30 K. pneumoniae, 1 E. coli, 2 C. freundii and 1 E. cloacae) were typed also by MLST [53] [54] [55] [56] ; databases available at http:// pubmlst.org/cfreundii/ (C. freundii), http://pubmlst.org/ecloacae (E. cloacae), http://mlst.warwick.ac.uk/mlst/dbs/Ecoli (E. coli) and http://bigsdb.web.pas teur.fr/klebsiella/klebsiella.html (K. pneumoniae) were used for assigning STs. The cps-1 and -2 capsular STs specific for two K. pneumoniae ST258/ ST512 clades were identified by multiplex PCR. 19 The potential ST258/ ST512-specific factors pilv-1, IS66 and prp, 20 were assessed by PCR in 30 K. pneumoniae isolates.
Plasmid analysis
Plasmid profiles were revealed for 63 representative isolates by nuclease S1 analysis (TaKaRa, Otsu, Japan). 57 Identification of bla KPC -carrying plasmids was done by hybridization of S1 patterns with a bla KPC probe, using the Amersham ECL Direct Nucleic Acid Labeling System (GE Healthcare, Little Chalfont, UK). Plasmids of 22 isolates were purified with the QIAGEN Plasmid Midi Kit (QIAGEN, Hilden, Germany) and electroporated into E. coli DH5a. Transformants were selected with 0.5 mg/L imipenem. Plasmids of the transformants were purified and subjected to PstI (Thermo Scientific) restriction fingerprinting and PCR-based replicon typing (PBRT).
44,58-61 PCR mapping of pKpQIL-like plasmids was performed as described previously. 15 
Susceptibility testing
Antimicrobial susceptibility of 22 selected isolates and their 14 E. coli transformants was tested using MIC Test Strips (Liofilchem, Roseto degli Abruzzi, Italy). Results were interpreted according to EUCAST (http://eucast.org) or, in the case of tetracycline, to CLSI.
62 Figure 1 . Geographical distribution of KPC-producing K. pneumoniae CG258 cases reported in Poland in 2010-12, based on the molecular and epidemiological data. Outbreaks and sporadic cases are represented by circles with diverse patterns corresponding to the individual CG258 genotypes, described in the text and shown in Table 2 . Similar patterns used for Swiętokrzyskie and Lubelskie reflect the relatedness of isolates in the two regions. Genotypic identity of isolates in Mazowieckie has been based on previous studies, carried out on isolates from 2008 to 2009 15, 22, 46 and several isolates analysed in this work. Sizes of the circles are not strictly proportional to numbers of cases. Continuous arrows represent transmission events documented by the epidemiological data. Broken arrows represent possible transmission events suggested by molecular characteristics of the study isolates.
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Results and discussion
KPC epidemiology in Poland in 2010-14
In 2008-09 a total of 114 KPC cases occurred in Poland, mainly due to the rapid outbreak in Warsaw and the Mazowieckie region (Table 1) . 15, 45 The predominant organism was K. pneumoniae ST258 KPC-2 carrying the Tn4401a transposon on the IncFII K ! FIB K pKpQIL-like or non-typeable plasmids, 15 classified by WGS into clade I. 22 In 2010-14 Mazowieckie recorded a gradual decrease in new KPC cases from the peak of 125 cases in 2010 to 13 cases in 2014, indicative of endemicity (Table 1) . However, new outbreaks commenced in other provinces, Swiętokrzyskie, Lubelskie, Podlaskie and Sla˛skie, and since 2012, these together comprised the majority of all KPC cases. Apart from the outbreaks, 21 cases were identified in other locales, including the cities of Olsztyn, Ł od z and Krak ow; occasionally forming smaller clusters. Of all the 608 patients affected in 2010-14, 209 (34.4%) were KPC carriers only, based on the hospital data. The remaining 399 patients had one or more infections, i.e. urinary tract (n " 210; 51.6%), respiratory tract (n " 88; 21.6%), skin and soft tissue (n " 61; 15.0%), bloodstream (n " 41; 10.1%) and intraabdominal infections (n " 7; 1.7%). The broad geographical spread might suggest KPC transfers from Warsaw and Mazowieckie to the new regions or between these; therefore, the 2010-12 isolates from the new outbreaks and sporadic cases were analysed in detail. Swię tokrzyskie and Lubelskie Swiętokrzyskie and Lubelskie were the only two regions that probably were affected by the same K. pneumoniae genotype. The organism was identified first in February 2010 in a teaching hospital in Lublin, the main city of Lubelskie, as the only isolate in that year (Table 1) . However, starting in April 2010 it caused an outbreak in Swiętokrzyskie, which until February 2011 included 20 patients in five institutions in four locales, with 15 patients in a regional pulmonary disease centre. The outbreak was controlled and only three more cases were reported in 2012-13. In November 2011, the hospital in Lublin commenced reporting an outbreak, which by the end of 2012 comprised 36 cases in five hospitals in three towns. The outbreak isolates from both provinces were very similar. The genotype was characterized by ST258, clade II, pilv-1, KPC-3 encoded by the Tn4401b variant in 80 kb IncI2-like plasmids, and co-expression of SHV-12 and TEM-1 ( Table 2 ). The only significant variation was the ESBL CTX-M-3 in the outbreak isolates in Lubelskie, correlating with one additional plasmid (90 kb) in their S1 profiles (results not shown). The outbreak isolates clearly differed from K. pneumoniae ST258 KPC-3 from one patient in Swiętokrzyskie in 2012, admitted after hospitalization in Italy. All of the results indicated that the two regions shared the epidemic K. pneumoniae genotype but due to scarcity of clinical epidemiology data one cannot indicate the undisputable transmission direction. Probably in 2011 the strain diversified in Lublin, acquiring a pCTX-M-3-like plasmid, broadly spread in Poland since the 1990s. 49, 63, 64 In 2013-14, 73 new KPC-positive patients were recorded in five hospitals of three cities in Lubelskie, of whom 64 patients were in the first outbreak site in Lublin. Several patient transfers from there were reported.
Podlaskie
In spring 2011 two different university hospitals in Białystok, the main city of Podlaskie, with no epidemiological links with each other, started recording KPC cases, followed by other centres (7) 64 (8) 50 (2) 27 (1) (3) 150 (7) 103 (9) 156 (4) 110 (5) 89 (2) 608 722 n hospitals (n new sites in a year)
5 (5) 18 (13) 33 (22) 30 (18) 36 (16) 23 (6) One of these patients (in Pozna n) was admitted directly after hospitalization in Greece.
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( Table 1 ). The analysis of the isolates from the entire region has confirmed the preliminary view of two separate outbreaks ( Table 2 ). The larger one comprised 31 cases in eight institutions of four towns by the end of 2012. The organism was K. pneumoniae ST258 of clade II, non-related by PFGE to others under study, having pilv-1 and prp, and producing KPC-3 encoded by Tn4401a. The element was located on related plasmids of 140-150 kb, which had an 'FII Y -like' replicon alone or with FII. All of the isolates co-produced TEM-1. The minor outbreak involved nine cases in three hospitals in three towns. Apart from one patient with E. coli ST1196, others had K. pneumoniae ST258 clade II of another specific pulsotype, with KPC-3, Tn4401b, pilv-1 and in some cases IS66. The bla KPC-3 -carrying plasmids varied; only those 80-85 kb were transferred and contained 'FII Y -like' and R replicons or both these plus FII. All of the isolates expressed TEM-1 but some also had CTX-M-3. The 'FII Y -like' amplicons obtained with FII Y replicon-specific primers 59 for isolates of both outbreaks were sequenced and were only 85% identical to the original fragment of Yersinia pestis plasmids 59 suggesting that these plasmids carried a new FII-like replicon. By BLAST N, similar replicons have been rare in Klebsiella spp., including one KPC-2-encoding plasmid pKPC-727 from K. oxytoca in the USA (GenBank accession no. CP008791.1). The results showed a complex situation in Podlaskie, with spread of two different ST258 subclones. In 2013-14, the region recorded 33 new cases, all in the larger outbreak sites. 
Other acquired b-lactamases include ESBLs and broad-spectrum b-lactamases.
b MLST of K. pneumoniae was performed for 30 representative isolates, based on the origin and PFGE subtypes. c PCRs for pilv-1, IS66 and prp were performed for 30 representative K. pneumoniae isolates selected as above; ! and # indicate positive and negative PCR results, respectively, for all isolates of a given subgroup tested; !/# indicates variation inside a subgroup. d bla KPC sequencing was performed for 34 representative isolates (30 K. pneumoniae, 1 E. coli, 2 C. freundii and 1 E. cloacae), based on the origin, species and PFGE subtypes; for the remaining isolates the data are based on the RsaI digest of bla KPC amplicons, distinguishing between bla KPC-2 and bla KPC-3 sequences. 47 e S1 analysis with bla KPC hybridization was performed for 63 representative isolates, considering the origin, species and PFGE subtypes; the results shown refer only to the plasmids hybridizing with the bla KPC probe. f bla KPC -carrying plasmids found in E. coli transformants are shown in bold; electroporation was performed for 22 representative isolates, based on the origin, species and S1 data, and was successful in 14 cases. g Fingerprint patterns and the majority of replicons refer to the bla KPC -carrying plasmids found in the E. coli transformants and are shown in bold; replicons in italics represent the probable types of bla KPC plasmids (PBRT and pKpQIL mapping were performed on DNA of clinical isolates). h Symbol 'FII Y ' is in quotes to indicate multiple nucleotide differences in the 'FII Y ' PBRT amplicons when compared with the FII Y replicon.
i
Sequencing of bla genes was performed for 20 representative isolates, based on origin, species, PFGE, isoelectric focusing and bla gene PCR profiling data. j K. pneumoniae isolates in these outbreak groups were internally diverse in terms of bla KPC -carrying plasmids (and other b-lactamases in the Podlaskie 2 outbreak); therefore, the data are shown in several lines for each of these.
KPCs in Poland
JAC Sla˛skie
The first KPC-producing isolates in Sla˛skie were identified in 2010 in two hospitals, arising from small and quickly controlled outbreaks following admissions of KPC-positive patients from other areas ( Table 1 ). The index cases were from Warsaw and Swiętokrzyskie (Kielce), respectively, and the isolates matched well the K. pneumoniae ST258 genotypes of both locations (Table 2) . In November 2011, Sla˛skie started reporting a new and region-wide outbreak, which rapidly progressed in 2012 to reach the number of 58 cases in 11 hospitals in 10 towns, including 34 cases in a secondary general hospital in Bielsko-Biała. The epidemic organism was K. pneumoniae ST512 clade II, having pilv-1 and IS66, and producing KPC-3 encoded by Tn4401a. It varied in plasmid profiles and bla KPC plasmids; seven selected isolates produced E. coli transformants with bla KPC plasmids of 110 or 50 kb. The larger ones were the IncFII K ! FIB K molecules of the pKpQIL type, as shown by the PCR assay, 15 while the smaller ones typed as IncX3. The only additional b-lactamase produced by the outbreak isolates was TEM-1. The isolates with pKpQIL were indistinguishable in all of the markers tested from the recently reported 19 K. pneumoniae ST512 KPC-3 isolates from 2009 to 2011 from a hospital in Rome, Italy. 17 In 2013-14 numbers of new KPC cases in Sla˛skie decreased to 27 and 10 patients, respectively, in parallel to enhanced infection control measures in many centres.
Other cities
Two C. freundii and one E. cloacae isolate from Warsaw were the only non-K. pneumoniae KPC producers in Mazowieckie in 2010-12. Consistent with the previous data from this region, 15 these produced KPC-2 encoded by Tn4401a ( Table 2 ). The C. freundii isolates belonged to ST17, which was originally identified with the MBL VIM-1 in Latvia. 65 The E. cloacae isolate represented ST254, first reported with KPC-3 in the USA. 66 Olsztyn, Ł od z and Krak ow were the only places outside the outbreak regions where KPC cases were reported in 2010-12. There was no epidemiological information on their origins; however, molecular data suggested possible in-country transmissions. The KPC-2-producing K. pneumoniae ST258 organisms from Olsztyn and Ł od z resembled those from Warsaw, 15, 22 while the ST512 KPC-3 producers from Krak ow were similar to the epidemic genotype in Sla˛skie.
Susceptibility testing
Most of the 22 selected isolates showed the usual phenotype of KPC producers (Table S1 , available as Supplementary data at JAC Online), with uniform resistance to all b-lactams, ciprofloxacin and tetracycline (at varying levels for some compounds). A significant fraction of selected isolates was susceptible to gentamicin (12 of 22) , and less so to amikacin (5 of 22). The MICs of tigecycline and colistin were low, with only two and one resistant isolates, respectively.
Conclusions
For several years, since 2008, the KPC spread was the major component of CPE epidemiology in Poland and it was dominated by the sequence of regional outbreaks, first in Warsaw and Mazowieckie, and then in other regions. The previous data on the Mazowieckie isolates from 2008 to 2009 15, 22 and this report on the 2010-12 isolates from the remaining areas revealed that the new outbreaks were not due to the spread of the 'early' KPC-2 organisms but to independent introductions of different K. pneumoniae ST258/ST512 KPC-3 lineages. Such discrimination requires applying typing approaches of higher resolution, e.g. WGS, [22] [23] [24] 41 or the combined analysis of several markers as used here. Considering the likely interregional transmission between Swiętokrzyskie and Lubelskie but also two separate outbreaks in Podlaskie, one may postulate at least four new KPC imports to Poland following the first KPC outbreak in Warsaw and Mazowieckie. Their origins may be hypothesized only; one of the first patients in Podlaskie (major outbreak) had been hospitalized in the USA, whereas the ST512 genotype in Sla˛skie was closely related to that spreading in Italy since 2008-09. 17 The enhanced infection control measures in hospitals resulted in significant reductions of new KPC cases; in Swiętokrzyskie, Podlaskie and Sla˛skie it was observed by the end of 2014, and in Lubelskie in 2015-16 (D. _ Zabicka, A. Baraniak, M. Gniadkowski and W. Hryniewicz, unpublished results). The measures comprised extensive screening of hospitalized patients (including regular point prevalence studies), standard isolation, strict precaution procedures, enhanced hand hygiene, reevaluation of antimicrobial stewardship and implementation of the on-admission screening in regional medical care institutions. The study has confirmed the correlation between the ST258/ ST512 clades II and I, and KPC-3 and -2, respectively, 19, 21, 23, 24 and the possible role of pilv-1, but not IS66 and prp, as the ST258/ ST512 clonal marker. 20 All three of these, however, may be useful ST258/ST512 internal diversity markers. The apparent control of the outbreaks has meant that KPCs no longer represent the firstline problem in the CPE epidemiology in Poland; since 2013 it has been marked mainly by the spread of the New Delhi MBLproducing K. pneumoniae.
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